Number of Indians hesitant to take Covid-19 vaccine rise, survey shows

Many Indians appear hesitant to get vaccinated for Covid-19 as infections have fallen sharply since a mid-September peak and some people are worried about possible side-effects, according to a survey

Topics
India | Coronavirus Vaccine | Coronavirus Tests

Reuters  |  Mumbai 

Coronavirus test, vaccine
A person gets Covid-19 vaccine shot in India during a trial

Many Indians appear hesitant to get vaccinated for COVID-19 as infections have fallen sharply since a mid-September peak and some people are worried about possible side-effects here, according to a survey of 18,000 people released on Thursday.

reported 24,037 new infections on Thursday - fewer than 30,000 for a fourth straight day - taking its total to 9.96 million, the second highest in the world. More than 144,000 people have died.
.

Until early last month, had looked set to overtake the infection tally of the United States but the gap between them has since widened significantly. U.S. cases have now risen to more than 16 million.
.

The government says it could soon approve some of the vaccines that have sought emergency use authorization, including the Oxford-AstraZeneca one and the Pfizer/BioNTech shot, which is already being used in the United States and Britain.

wants to roll out vaccines here in a few weeks, initially focusing on people more exposed to the virus and over 50, but a survey by New Delhi's citizen-survey platform LocalCircles found that about 69% of respondents saw no urgent need to get immunized.
.

“It appears some of the key reasons for the hesitancy are limited information about side-effects, efficacy levels and a growing belief in parts of the population that COVID cannot affect them because of their high immunity levels,” LocalCircles said in a statement.
.

Many people in the survey, which had responses from nearly a third of India’s districts, said they believed “we are moving towards herd immunity”.

Jiaul Haque, a software engineer from the eastern state of Assam, said he thought he had already developed some kind of immunity to COVID-19 and would like to see how the various vaccines work on other people before he signs up for one.
.

“The vaccine has not passed the regular duration of testing,” the 36-year-old said.
.

“All vaccine companies are in a race against each other, so I’m also concerned about that.”

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on India